McCormac Paul - Insider Non-Derivative Transactions at Lexeo Therapeutics, Inc. (LXEO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Nov 7, 2023, McCormac Paul's relationship to Lexeo Therapeutics, Inc. (LXEO) is Officer (Chief Technical Officer), and currently has 17,349 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other LXEO insiders.
Data Source: SEC.
McCormac Paul - Insider Non-Derivative Transactions at LXEO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Nov 8, 2023 | C -- (Common Stock) | 3191 | 0 | 17349 |